On the other hand, NGF has been increasingly described to regulate tumor growth and progression of non-neuronal cancers including medullar thyroid carcinoma [17], lung [18], pancreatic [19], prostatic [20] and breast carcinomas [21-23]. This evidence concerns the gene NGF and breast carcinoma.